ALPROLIX® [Coagulation Factor IX (Recombinant), FC Fusion Protein] Financial Assistance Programs

Sanofi Genzyme is committed to helping qualified patients receive access to ALPROLIX® and appropriate financial support through our financial assistance programs.

Financial assistance programs* available

  • Free Trial Plus Program:
    • Allows eligible patients a 30-day trial of Alprolix with a valid prescription.
    • Quick shipment: Usually 24-48 hours after approval.
    • If insurance coverage issues exist after 30-day trial period, we may be able to provide further assistance if certain eligibility requirements are met.
  • Copay Program:
    • Helps eligible patients obtain assistance with monthly co-payments or co-insurance up to $20,000 per year.
    • No income criteria.
    • Fast enrollment.
    • Can retroactively cover up to 120 days in the past, if needed.
  • Factor Access Program:
    • Designed for people who:
      • Have no insurance.
      • Reached their insurance cap.
      • Have a lapse in insurance coverage.
      • Have an insurer who does not cover the product that has been prescribed.

Those with federal and state government insurance, such as Medicare, Medicaid, or TRICARE® are not eligible. Other eligibility requirements may apply. Sanofi Genzyme reserves the right to modify or discontinue the programs at any time.

Contact details

Case managers are available Monday-Friday 8:00 a.m. to 8:00 p.m. ET by calling 1-855-692-5776.

For more information

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies.